BNTC
Benitec Biopharma Ltd ADR
NASDAQ: BNTC · HEALTHCARE · BIOTECHNOLOGY
$12.05
-0.82% today
Updated 2026-04-30
Market cap
$423.73M
P/E ratio
—
P/S ratio
2,770.13x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$10 – $17
Volume
0.2M
Benitec Biopharma Ltd ADR (BNTC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-9.27M | $-9.69M | $-9.69M | $-20.21M | $-8.30M | $-8.55M | $4.79M | $-7.54M | $-12.83M | $-15.90M | $-18.01M | $-19.40M | $-23.59M |
| Capital expenditures | $29203.00 | $475455.00 | $387335.00 | $255399.00 | $131405.00 | $60971.00 | $403395.00 | $95000.00 | $221000.00 | $13000.00 | $1000.00 | $179000.00 | $18000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | $386000.00 | — | $957196.00 | $237000.00 | $634000.00 | $870000.00 | $452000.00 | $830000.00 | $17.43M |
| Free cash flow | $-9.30M | $-10.17M | $-10.08M | $-20.46M | $-8.44M | $-8.61M | $4.39M | $-7.63M | $-13.05M | $-15.91M | $-18.01M | $-19.58M | $-23.61M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | $619000.00 | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-5.92M | — | — | — | — | — |